Anti-NMDAR antibodies are not prevalent in Lyme neuroborreliosis: a retrospective cohort study
Anti-NMDAR antibodies were not detected in the CSF of LNB patients, suggesting their presence is rare in this population at diagnosis. Although the sample size may limit statistical power, the absence of later clinical suspicion or testing supports the hypothesis that LNB is an uncommon trigger for anti-NMDAR encephalitis.
Authors
- Morten Blaabjerg (ORCID: https://orcid.org/0000-0001-6007-1861)
- Helene Mens (ORCID: https://orcid.org/0000-0001-8665-1418)
- Anna Christine Nilsson (ORCID: https://orcid.org/0000-0001-7885-8400)
- Anna Maria Florescu (ORCID: https://orcid.org/0000-0001-6642-2917)
- Anne‐Mette Lebech (ORCID: https://orcid.org/0000-0002-0943-3289)
- Thomas Bryrup (ORCID: https://orcid.org/0000-0001-8533-6766)
Institutions
- University of Copenhagen (DK)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1186/s12883-025-04513-w
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00